| 2065 |
1740: ACE2 enzymatic inhibition |
1752: Increased AngII |
Mar 17, 2020 |
Mar 17, 2020 |
1 AOP
|
| 2321 |
1740: ACE2 enzymatic inhibition |
1741: Induced, Angiotensin (Ang) II accumulation |
Apr 10, 2021 |
Apr 10, 2021 |
None
|
| 2434 |
1740: ACE2 enzymatic inhibition |
1743: Increase plasma Ang II |
Jul 13, 2021 |
Jul 13, 2021 |
1 AOP
|
| 1323 |
1257: Induced parturition |
1141: Decreased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
1 AOP
|
| 1326 |
1257: Induced parturition |
1163: Increased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
1 AOP
|
| 1324 |
1255: induced spawning |
1141: Decreased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
None
|
| 1325 |
1255: induced spawning |
1163: Increased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
1 AOP
|
| 2295 |
1741: Induced, Angiotensin (Ang) II accumulation |
1849: Impaired gustatory nerve |
Mar 28, 2021 |
Mar 28, 2021 |
None
|
| 2322 |
1741: Induced, Angiotensin (Ang) II accumulation |
1852: Increased Ang II type 1 receptor (AT1R) |
Apr 10, 2021 |
Apr 10, 2021 |
None
|
| 2520 |
1741: Induced, Angiotensin (Ang) II accumulation |
1853: Hyperactivation of ACE/Ang-II/AT1R axis |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 1961 |
1666: dysfunction of microcirculation |
1667: anterior-posterior axis development |
Jul 3, 2019 |
Jul 3, 2019 |
1 AOP
|
| 2512 |
1666: dysfunction of microcirculation |
1750: Increased inflammatory immune responses |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 1221 |
1167: induced, parturition |
1141: Decreased, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2021 |
1711: Induction of GATA3 expression |
1712: Increase of Th2 cells producing IL-4 |
Dec 29, 2019 |
Aug 14, 2020 |
1 AOP
|
| 2538 |
1959: Induction of hERG trafficking defects |
1960: Inhibition of Ikr |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 1630 |
1459: Cell damage sensing |
1455: Sustained inflammatory cytokine release |
Jul 26, 2017 |
Jul 26, 2017 |
None
|
| 1632 |
1459: Cell damage sensing |
1032: Increased, secretion of local growth factors |
Jul 26, 2017 |
Jul 26, 2017 |
None
|
| 70 |
60: Induction, Chitin degradation and resorption |
238: Induction, Pre-mature molting |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 868 |
850: Induction, CYP1A2/CYP1A5 |
844: Oxidation, Uroporphyrinogen |
Nov 29, 2016 |
May 31, 2018 |
1 AOP
|
| 3275 |
850: Induction, CYP1A2/CYP1A5 |
1392: Increase, Oxidative Stress |
Jul 4, 2024 |
Jul 4, 2024 |
1 AOP
|
| 1262 |
1206: Induction, Doublesex1 gene |
1209: Induction, Male reproductive tract |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 386 |
145: Induction, IKB inhibitory protein |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 170 |
164: Induction, Liver “Dysfunctional” Changes by CGA 330050 |
147: Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1263 |
1209: Induction, Male reproductive tract |
1208: Increased, Male offspring |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 859 |
838: Induction, Microvesicular fat |
840: Formation, Liver fibrosis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|